DeLorean Artificial Intelligence

Our flagship medical AI solution, MARTI, is the first #ai in the world to be biologically validated and saves $100PMPM

Founded 2019

Palm Beach, United States 24 employees Series A Total: $18.00M AI, Information Technology

DeLorean Artificial Intelligence is a pioneering AI startup with a focus on the development and application of innovative AI solutions. Established in 2019 and headquartered in the United States, the company has gained recognition for its flagship medical AI solution, MARTI, which has been biologically validated and is shown to save an impressive $100PMPM. DeLorean AI's offerings are tailored to address business challenges across a range of industries, including Healthcare Payer, Life Sciences, Financial, Fintech, M&A, CPG, HR Talent, and Entertainment. The company has positioned itself as a leader in harnessing the return on investment from both structured and unstructured data, catering to Fortune 500 companies. One of their key innovations is a patent-pending predictive and interventive artificial intelligence system, which can accurately forecast the likelihood of future events and provide intervention strategies to optimize outcomes for their client companies. In September 2023, the company secured a significant $7.50M Series A investment, with backing from prominent investors including Sopris Capital and Pinta Capital Partners. As DeLorean AI continues to carve a path in the AI and Information Technology sectors, it has positioned itself as a promising player in the evolving landscape of artificial intelligence and its applications.

Funding Stage	Amount	Investors	Lead Investors	Date
Series A	$7.50M	2	Sopris Capital, Pinta Capital Partners	11 Sep 2023
Series A	$7.50M	2	Pinta Capital Partners, Sopris Capital Associates	01 Aug 2023
Seed Round	$3.00M	-		28 Feb 2022

Funding Stage

Amount

Investors

Lead Investors

Date

Series A

$7.50M

Sopris Capital, Pinta Capital Partners

11 Sep 2023

Series A

$7.50M

Pinta Capital Partners, Sopris Capital Associates

01 Aug 2023

Seed Round

$3.00M

28 Feb 2022

FAQ About DeLorean Artificial Intelligence

Our flagship medical AI solution, MARTI, is the first #ai in the world to be biologically validated and saves $100PMPM

DeLorean Artificial Intelligence was founded in 2019.

DeLorean Artificial Intelligence is headquartered in Palm Beach, United States.

DeLorean Artificial Intelligence operates in AI and Information Technology. Its work centres on Healthcare Payer, Life Sciences, Financial and M&A. Its customers include Health insurers, care providers and and healthcare organizations seeking to proactively manage and mitigate significant health risks.

DeLorean Artificial Intelligence has approximately 24 employees.

DeLorean Artificial Intelligence has completed 3 funding rounds, raising a total of $18.00M. The latest funding stage is Series A.

DeLorean Artificial Intelligence offers: Development and deployment of predictive and personalized healthcare AI solutions for chronic disease management, risk stratification, and medical cost reduction..

Top alternatives and competitors to DeLorean Artificial Intelligence include Partex.AI Technology, Legitary. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

DeLorean Artificial Intelligence and Partex.AI Technology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

DeLorean Artificial Intelligence

General Information

Discover More

About DeLorean Artificial Intelligence

Services & Products

Target Customers

Funding Rounds & Investors (3)

DeLorean Artificial Intelligence Alternatives & Competitors

FAQ About DeLorean Artificial Intelligence